PTH and chronic kidney disease: The resulting endocrine profile that characterizes patients with CKD –high FGF-23 and PTH, with low calcitriol and α-Klotho—contributes to cardiovascular morbidity, systemic inflammation, dysregulation of bone metabolism, and anemia.